ATC code - C02A
SpainAntiadrenergic agents, centrally acting
Drugs with code C02A
-
Form: tablets, film-coated
Active substance Dosage methyldopa 283 mg ATC code: C02A, C02AB, C02AB01
Manufacturer: H.A.C. Pharma
-
Form: tablets, film-coated
Active substance Dosage methyldopa 566 mg ATC code: C02A, C02AB, C02AB01
Manufacturer: H.A.C. Pharma
-
Form: tablets
Active substance Dosage clonidine hydrochloride 0,150 mg ATC code: C02A, C02AC, C02AC01
Manufacturer: Glenwood Gmbh Pharmazeutische Erzeugnisse
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,14 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,28 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,42 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,56 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
Form: tablets, film-coated
Active substance Dosage moxonidine 0,2 mg ATC code: C02A, C02AC, C02AC05
Manufacturer: Viatris Healthcare Limited
-
Form: tablets, film-coated
Active substance Dosage moxonidine 0,3 mg ATC code: C02A, C02AC, C02AC05
Manufacturer: Viatris Healthcare Limited
-
Form: tablets, film-coated
Active substance Dosage moxonidine 0,4 mg ATC code: C02A, C02AC, C02AC05
Manufacturer: Viatris Healthcare Limited
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,148 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,296 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,444 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,592 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 5,740 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 6,88 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 8,036 mg ATC code: C02A, C02AC, C02AC02
Manufacturer: Neuraxpharm Pharmaceuticals S.L.